Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.

Tularemia is an important reemerging disease with a multimodal transmission pattern. Treatment outcomes of current recommended antibiotic regimens (including ciprofloxacin and doxycycline) remain unclear. In this retrospective cohort study, we report clinical, laboratory, geographical, and treatment...

Full description

Bibliographic Details
Published in:Clinical Infectious Diseases
Main Authors: Plymoth, Martin, Lundqvist, Robert, Nystedt, Anders, Sjöstedt, Anders, Gustafsson, Tomas N
Format: Article in Journal/Newspaper
Language:English
Published: Silverchair Information Systems 2024
Subjects:
Francisella tularensis
ciprofloxacin
doxycycline
outcome
treatment
Northern Sweden
Online Access:https://doi.org/10.1093/cid/ciae098
https://pubmed.ncbi.nlm.nih.gov/38393822
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093680/
id ftpubmed:38393822
record_format openpolar
spelling ftpubmed:38393822 2024-06-09T07:48:35+00:00 Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden. Plymoth, Martin Lundqvist, Robert Nystedt, Anders Sjöstedt, Anders Gustafsson, Tomas N 2024 May 15 https://doi.org/10.1093/cid/ciae098 https://pubmed.ncbi.nlm.nih.gov/38393822 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093680/ eng eng Silverchair Information Systems https://doi.org/10.1093/cid/ciae098 https://pubmed.ncbi.nlm.nih.gov/38393822 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093680/ © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. Clin Infect Dis ISSN:1537-6591 Volume:78 Issue:5 Francisella tularensis ciprofloxacin doxycycline outcome treatment Journal Article Observational Study 2024 ftpubmed https://doi.org/10.1093/cid/ciae098 2024-05-16T16:03:00Z Tularemia is an important reemerging disease with a multimodal transmission pattern. Treatment outcomes of current recommended antibiotic regimens (including ciprofloxacin and doxycycline) remain unclear. In this retrospective cohort study, we report clinical, laboratory, geographical, and treatment outcomes of laboratory-confirmed tularemia cases over an 11-year period in Northern Sweden. Article in Journal/Newspaper Northern Sweden PubMed Central (PMC) Clinical Infectious Diseases 78 5 1222 1231
institution Open Polar
collection PubMed Central (PMC)
op_collection_id ftpubmed
language English
topic Francisella tularensis
ciprofloxacin
doxycycline
outcome
treatment
spellingShingle Francisella tularensis
ciprofloxacin
doxycycline
outcome
treatment
Plymoth, Martin
Lundqvist, Robert
Nystedt, Anders
Sjöstedt, Anders
Gustafsson, Tomas N
Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.
topic_facet Francisella tularensis
ciprofloxacin
doxycycline
outcome
treatment
description Tularemia is an important reemerging disease with a multimodal transmission pattern. Treatment outcomes of current recommended antibiotic regimens (including ciprofloxacin and doxycycline) remain unclear. In this retrospective cohort study, we report clinical, laboratory, geographical, and treatment outcomes of laboratory-confirmed tularemia cases over an 11-year period in Northern Sweden.
format Article in Journal/Newspaper
author Plymoth, Martin
Lundqvist, Robert
Nystedt, Anders
Sjöstedt, Anders
Gustafsson, Tomas N
author_facet Plymoth, Martin
Lundqvist, Robert
Nystedt, Anders
Sjöstedt, Anders
Gustafsson, Tomas N
author_sort Plymoth, Martin
title Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.
title_short Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.
title_full Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.
title_fullStr Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.
title_full_unstemmed Targeting Tularemia: Clinical, Laboratory, and Treatment Outcomes From an 11-year Retrospective Observational Cohort in Northern Sweden.
title_sort targeting tularemia: clinical, laboratory, and treatment outcomes from an 11-year retrospective observational cohort in northern sweden.
publisher Silverchair Information Systems
publishDate 2024
url https://doi.org/10.1093/cid/ciae098
https://pubmed.ncbi.nlm.nih.gov/38393822
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093680/
genre Northern Sweden
genre_facet Northern Sweden
op_source Clin Infect Dis
ISSN:1537-6591
Volume:78
Issue:5
op_relation https://doi.org/10.1093/cid/ciae098
https://pubmed.ncbi.nlm.nih.gov/38393822
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11093680/
op_rights © The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
op_doi https://doi.org/10.1093/cid/ciae098
container_title Clinical Infectious Diseases
container_volume 78
container_issue 5
container_start_page 1222
op_container_end_page 1231
_version_ 1801380366153416704

Similar Items